Detalhe da pesquisa
1.
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors.
Clin Gastroenterol Hepatol
; 21(2): 406-414.e7, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124272
2.
High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease.
Liver Int
; 43(7): 1446-1457, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912787
3.
Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.
Int J Mol Sci
; 24(7)2023 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37047094
4.
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.
Int J Mol Sci
; 24(9)2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37175497
5.
National digestive disease specialists survey on cardiovascular risk management in non-alcoholic fatty liver disease in spanish hospitals.
Liver Int
; 41(6): 1243-1253, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527637
6.
Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review.
J Clin Med
; 11(21)2022 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362663
7.
Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy.
Therap Adv Gastroenterol
; 15: 17562848221077837, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35251307
8.
Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).
Trials
; 22(1): 756, 2021 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34717726